pandemic influenza a h1n1 vaccine in recipients of solid organ transplants: immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination. | during the 2009/10 pandemic of influenza a (h1n1), the american society of transplantation and other health organizations recommended that immunocompromised patients should be vaccinated as the key preventive measure. since there are no data available for the immunogenicity of the unadjuvanted pandemic influenza vaccine in immunocompromised patients - as opposed to the adjuvanted preparation - the objective of this study was to evaluate the immunogenicity of an adjuvant-free h1n1 vaccine in reci ... | 2011 | 21803100 |